Company
Mayne Pharma
Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
13
11 still marketed
Novel approvals
3
Approvals since 2021
5
Originals and new uses
Phase 3 trials
2
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (11)
Newest FDA action first.
- Annovera Ethinyl Estradiol, Segesterone Acetate · 2018
- Bijuva Estradiol, Progesterone · 2018
- Doryx Mpc Doxycycline Hyclate · 2005
- Tolsura Itraconazole · 2018
- Imvexxy Estradiol · 2018
- Nextstellis Drospirenone, Estetrol · 2021
- Epsolay Benzoyl Peroxide · 2022
- Twyneo Benzoyl Peroxide, Tretinoin · 2021
- Sorilux Calcipotriene · 2010
- Rhofade Oxymetazoline Hydrochloride · 2017
- Fabior Tazarotene · 2012
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.